Perceptions and Barriers About Cessation of Smoking Among IBD Patients

NCT ID: NCT05182996

Last Updated: 2022-01-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

350 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-08-15

Study Completion Date

2022-10-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will investigate the perception of the relationship between smoking and inflammatory bowel disease by surveying inflammatory bowel disease patients. Afterward, the relationship between smoking and inflammatory bowel disease will be explained, and the smoking cessation rate will be investigated three months later.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A survey is conducted on patients with inflammatory bowel disease (IBD). Current smoking status, daily smoking amount, smoking period, perception of smoking effect on the induction of Crohn's disease (CD) or ulcerative colitis (UC), and perception of the effect of smoking on the course of CD or UC were investigated. Moreover, the intention to quit smoking is investigated. After the survey, information on the effects of smoking on CD or IBD is provided, and smoking cessation education is provided. After three months, the patients' smoking behavior was investigated, and the smoking cessation rate was investigated.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Smoking Inflammatory Bowel Diseases

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

smoking education

smoking education

Group Type OTHER

smoking education

Intervention Type BEHAVIORAL

Educate on the relationship between inflammatory bowel disease and smoking and the necessity and importance of quitting smoking.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

smoking education

Educate on the relationship between inflammatory bowel disease and smoking and the necessity and importance of quitting smoking.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients previously diagnosed with inflammatory bowel disease or newly diagnosed with inflammatory bowel disease

Exclusion Criteria

* Those who do not agree to the survey or smoking cessation education
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Keimyung University Dongsan Medical Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

YooJin Lee

Assistant Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

KeimyungUniversity

Daegu, Jung-gu, South Korea

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

South Korea

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

YooJin Lee, professor

Role: CONTACT

82-10-2755-0758

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Yoo Jin Lee

Role: primary

+82-250-7088

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2021-07-037

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Motivating Change in Aging Smokers
NCT05194917 COMPLETED NA
Connection to Health for Smokers
NCT03680599 COMPLETED NA